Alzheimer’s Disease and Dementia May Cost $1 Trillion by 2050
By Amanda Stewart, March 25th, 2018 | 2 Comments »
Today, about two-thirds of the cost to treat the disease sis borne by taxpayers — amounting to nearly $185 billion this yr.
The number of Americans with Alzheimer’s disease increased by 3.6% in just one year, to reach 5.7 million, according to a report by the Alzheimer’s Association. The number could reach as high as 13.8 million by 2050.
It is still difficult to estimate how many people are impacted by Alzheimer’s versus other forms of dementia due to the fact that they’re indistinguishable from one another in the early stages. Causes other than Alzheimer’s disease — such as Parkinson’s disease and stroke — makes up between 15% to 40% of all dementia cases.
Populations at Risk for Alzheimer’s Disease
“Different researchers can use different thresholds, and that can really impact the numbers,” Ron Brookmeyer told Forbes. The projections the new report indicating that “by 2050, we’re going to be seeing over a two-and-a-half-fold increase in Alzheimer’s dementia prevalence is pretty accurate, and that is really driven by the aging of the population.”
The aging population isn’t the only reason the numbers of people with the cognitive disease is increasing either. Genetics plays a factor here as well. If you have a family member that suffers from dementia or Alzheimer’s, you are more likely to develop the disease later in life.
Women are also more likely to develop Alzheimer’s disease than men: two-thirds of Alzheimer’s patients are women. Researchers have also noticed that African Americans and Hispanics are more likely to have Alzheimer’s later in life than whites. Asians are the least likely ethnicity to develop Alzheimer’s.
Cure Still Needed
Of the top 10 leading causes of death in the U.S., Alzheimer’s disease is the only one without a cure. There is also no way to prevent the disease or slow it down once it has been diagnosed. So far, there have been around 244 drugs created to help treat the symptoms of Alzheimer’s. However, only five have been approved by the Food and Drug Administration.
With the numbers of individuals predicted to develop dementia or Alzheimer’s disease within the next 30 years or so, there is an urgent need for more research. If the numbers continue to climb, it will begin costing taxpayers trillions of dollars a year, and millions of lives will be impacted by this difficult disease.
While the numbers are increasing, Alzheimer’s disease still only affects one in 10 Americans. There is a need to define better ways to treat and prevent the disease with numbers climbing though. Experts have called for more research to be done.
Readers, do you have family members with Alzheimer’s disease?
You may also enjoy reading:
A good friend of my parents had Alzheimers. She slowly lost her mind over a couple of years. It was painful to watch.
One can only hope that science is able to find a cure for Alzheimers quickly.
I was diagnosed five years ago at the age of 51. I had symptoms for 3-4 years prior to that but did not know anything about Parkinson’s. I first noticed a slight twitch in my left hand, finger and thumb, which became pill rolling. We attended a lot of sports events and I would lose my balance in the moving crowd. I then started seeing a neurologist. I started falling a lot when losing my balance and had a hard time walking normal. I finally froze up in the doorway at church. I told my Neuro and he said that I had Parkinson’s.